Stephen Willey
Stock Analyst at Stifel Nicolaus
(4.63)
# 903
Out of 4,690 analysts
610
Total ratings
48.1%
Success rate
12%
Average return
Main Sectors:
Stocks Rated by Stephen Willey
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PYXS Pyxis Oncology | Maintained: Buy | $8 → $7 | $3.23 | +116.72% | 7 | Aug 17, 2026 | |
| MGNX MacroGenics | Reiterated: Hold | $4 | $4.13 | -3.15% | 36 | Aug 14, 2026 | |
| SNDX Syndax Pharmaceuticals | Maintained: Buy | $40 | $19.54 | +104.71% | 10 | Aug 14, 2026 | |
| CELC Celcuity | Maintained: Buy | $175 → $150 | $88.44 | +69.61% | 11 | Aug 14, 2026 | |
| NKTX Nkarta | Maintained: Buy | $11 → $10 | $2.76 | +262.32% | 26 | Aug 14, 2026 | |
| CMPX Compass Therapeutics | Maintained: Buy | $6 | $2.40 | +150.00% | 14 | Aug 14, 2026 | |
| LYEL Lyell Immunopharma | Maintained: Buy | $36 | $14.53 | +147.76% | 2 | Aug 14, 2026 | |
| CADL Candel Therapeutics | Maintained: Buy | $22 | $13.07 | +68.32% | 2 | Aug 14, 2026 | |
| BCAX Bicara Therapeutics | Maintained: Buy | $46 → $45 | $23.43 | +92.06% | 15 | Aug 13, 2026 | |
| ZYME Zymeworks | Maintained: Buy | $46 | $28.27 | +62.72% | 34 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $35 | $18.03 | +94.12% | 6 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $4.47 | +101.34% | 11 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $47 → $51 | $54.45 | -6.34% | 55 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 → $9 | $11.35 | -20.70% | 19 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $30 → $28 | $17.75 | +57.75% | 18 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $111 | $80.03 | +38.70% | 11 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $123 → $145 | $124.37 | +16.59% | 40 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $200 | $118.54 | +68.72% | 30 | Jul 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $34 → $40 | $26.21 | +52.61% | 30 | Jul 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $40 | $22.65 | +76.60% | 24 | Apr 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $17 | $5.92 | +187.16% | 6 | Mar 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 → $7.5 | $4.04 | +85.64% | 17 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $28 | $6.59 | n/a | 1 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $25 → $20 | $3.82 | n/a | 12 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4 | $1.51 | n/a | 16 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4 | $27.88 | n/a | 15 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4 | $2.60 | n/a | 10 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $7 → $6 | $0.9804 | n/a | 17 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $6 → $5 | $5.89 | n/a | 6 | May 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $9 → $5 | $0.9645 | n/a | 4 | May 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $3 → $1 | $1.29 | n/a | 15 | May 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $25 → $27 | $1.20 | n/a | 4 | Mar 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $6 | $2.29 | n/a | 11 | Mar 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $18 → $21 | $59.99 | n/a | 5 | Mar 29, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $160 | $3.83 | n/a | 1 | Mar 14, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $95 → $125 | $237.10 | n/a | 6 | Aug 6, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $109 → $114 | $64.67 | n/a | 14 | Aug 6, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $55 → $48 | $61.05 | n/a | 13 | Aug 6, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $17 → $16 | $20.97 | n/a | 13 | Apr 27, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $13 → $2.5 | $0.000001 | n/a | 3 | Sep 26, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 → $26 | $12.38 | n/a | 2 | Apr 4, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 | $1.82 | n/a | 1 | Feb 2, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $23 | $9.60 | n/a | 1 | Dec 2, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $200 | $244.54 | n/a | 1 | May 31, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $8.10 | n/a | 5 | Dec 2, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $101 | - | n/a | 5 | Mar 31, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $31 → $26 | $5.07 | n/a | 3 | Nov 7, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 → $7 | $46.48 | n/a | 2 | Apr 8, 2013 |
Pyxis Oncology
Aug 17, 2026
Maintained: Buy
Price Target: $8 → $7
Current: $3.23
Upside: +116.72%
MacroGenics
Aug 14, 2026
Reiterated: Hold
Price Target: $4
Current: $4.13
Upside: -3.15%
Syndax Pharmaceuticals
Aug 14, 2026
Maintained: Buy
Price Target: $40
Current: $19.54
Upside: +104.71%
Celcuity
Aug 14, 2026
Maintained: Buy
Price Target: $175 → $150
Current: $88.44
Upside: +69.61%
Nkarta
Aug 14, 2026
Maintained: Buy
Price Target: $11 → $10
Current: $2.76
Upside: +262.32%
Compass Therapeutics
Aug 14, 2026
Maintained: Buy
Price Target: $6
Current: $2.40
Upside: +150.00%
Lyell Immunopharma
Aug 14, 2026
Maintained: Buy
Price Target: $36
Current: $14.53
Upside: +147.76%
Candel Therapeutics
Aug 14, 2026
Maintained: Buy
Price Target: $22
Current: $13.07
Upside: +68.32%
Bicara Therapeutics
Aug 13, 2026
Maintained: Buy
Price Target: $46 → $45
Current: $23.43
Upside: +92.06%
Zymeworks
Aug 11, 2026
Maintained: Buy
Price Target: $46
Current: $28.27
Upside: +62.72%
Aug 11, 2026
Maintained: Buy
Price Target: $35
Current: $18.03
Upside: +94.12%
Aug 7, 2026
Reiterated: Buy
Price Target: $9
Current: $4.47
Upside: +101.34%
Aug 6, 2026
Maintained: Hold
Price Target: $47 → $51
Current: $54.45
Upside: -6.34%
Aug 6, 2026
Maintained: Buy
Price Target: $8 → $9
Current: $11.35
Upside: -20.70%
Jul 31, 2026
Maintained: Buy
Price Target: $30 → $28
Current: $17.75
Upside: +57.75%
Jul 31, 2026
Maintained: Buy
Price Target: $111
Current: $80.03
Upside: +38.70%
Jul 28, 2026
Maintained: Buy
Price Target: $123 → $145
Current: $124.37
Upside: +16.59%
Jul 17, 2026
Maintained: Buy
Price Target: $200
Current: $118.54
Upside: +68.72%
Jul 10, 2026
Rated: Buy
Price Target: $34 → $40
Current: $26.21
Upside: +52.61%
Apr 8, 2026
Maintained: Buy
Price Target: $40
Current: $22.65
Upside: +76.60%
Mar 18, 2026
Maintained: Buy
Price Target: $17
Current: $5.92
Upside: +187.16%
Nov 5, 2025
Reiterated: Buy
Price Target: $9 → $7.5
Current: $4.04
Upside: +85.64%
Jun 24, 2025
Initiated Coverage: Buy
Price Target: $28
Current: $6.59
Upside: n/a
May 13, 2025
Reiterated: Hold
Price Target: $25 → $20
Current: $3.82
Upside: n/a
Mar 12, 2025
Maintained: Buy
Price Target: $4
Current: $1.51
Upside: n/a
Nov 15, 2024
Maintained: Buy
Price Target: $4
Current: $27.88
Upside: n/a
Nov 6, 2024
Maintained: Buy
Price Target: $4
Current: $2.60
Upside: n/a
May 14, 2024
Maintained: Hold
Price Target: $7 → $6
Current: $0.9804
Upside: n/a
May 13, 2022
Maintained: Hold
Price Target: $6 → $5
Current: $5.89
Upside: n/a
May 13, 2022
Maintained: Hold
Price Target: $9 → $5
Current: $0.9645
Upside: n/a
May 11, 2022
Maintained: Hold
Price Target: $3 → $1
Current: $1.29
Upside: n/a
Mar 12, 2021
Maintained: Buy
Price Target: $25 → $27
Current: $1.20
Upside: n/a
Mar 11, 2021
Maintained: Hold
Price Target: $6
Current: $2.29
Upside: n/a
Mar 29, 2019
Maintained: Buy
Price Target: $18 → $21
Current: $59.99
Upside: n/a
Mar 14, 2019
Maintained: Hold
Price Target: $160
Current: $3.83
Upside: n/a
Aug 6, 2018
Upgraded: Buy
Price Target: $95 → $125
Current: $237.10
Upside: n/a
Aug 6, 2018
Reiterated: Buy
Price Target: $109 → $114
Current: $64.67
Upside: n/a
Aug 6, 2018
Reiterated: Hold
Price Target: $55 → $48
Current: $61.05
Upside: n/a
Apr 27, 2018
Maintained: Hold
Price Target: $17 → $16
Current: $20.97
Upside: n/a
Sep 26, 2017
Downgraded: Hold
Price Target: $13 → $2.5
Current: $0.000001
Upside: n/a
Apr 4, 2017
Reiterated: Buy
Price Target: $20 → $26
Current: $12.38
Upside: n/a
Feb 2, 2017
Reiterated: Buy
Price Target: $24
Current: $1.82
Upside: n/a
Dec 2, 2016
Reiterated: Buy
Price Target: $23
Current: $9.60
Upside: n/a
May 31, 2016
Reiterated: Buy
Price Target: $200
Current: $244.54
Upside: n/a
Dec 2, 2015
Downgraded: Hold
Price Target: n/a
Current: $8.10
Upside: n/a
Mar 31, 2015
Downgraded: Hold
Price Target: $101
Current: -
Upside: n/a
Nov 7, 2014
Reiterated: Buy
Price Target: $31 → $26
Current: $5.07
Upside: n/a
Apr 8, 2013
Reiterated: Buy
Price Target: $11 → $7
Current: $46.48
Upside: n/a